Page last updated: 2024-10-20

pyridoxine and Vascular Malformations

pyridoxine has been researched along with Vascular Malformations in 1 studies

4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).

Vascular Malformations: A spectrum of congenital, inherited, or acquired abnormalities in BLOOD VESSELS that can adversely affect the normal blood flow in ARTERIES or VEINS. Most are congenital defects such as abnormal communications between blood vessels (fistula), shunting of arterial blood directly into veins bypassing the CAPILLARIES (arteriovenous malformations), formation of large dilated blood blood-filled vessels (cavernous angioma), and swollen capillaries (capillary telangiectases). In rare cases, vascular malformations can result from trauma or diseases.

Research Excerpts

ExcerptRelevanceReference
"To study the human risk and benefit of oral pyridoxine (vitamin B6) treatment during pregnancy."7.72Oral pyridoxine during pregnancy : potential protective effect for cardiovascular malformations. ( Acs, N; Bánhidy, F; Czeizel, AE; Puhó, E, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Czeizel, AE1
Puhó, E1
Bánhidy, F1
Acs, N1

Other Studies

1 other study available for pyridoxine and Vascular Malformations

ArticleYear
Oral pyridoxine during pregnancy : potential protective effect for cardiovascular malformations.
    Drugs in R&D, 2004, Volume: 5, Issue:5

    Topics: Adult; Case-Control Studies; Data Interpretation, Statistical; Databases, Factual; Dietary Supplemen

2004